Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...

Researchers found that activating the STING pathway with an experimental agonist reduced meningioma growth, triggered ...

Cancer tumors hijack the vagus nerve to communicate with the brain, triggering a hormonal response that suppresses the immune system.

The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.

Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have uncovered a ...

Even before a tumor in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment ...

Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score ...

Cancer is often described as a genetic roll of the dice. A matter of bad luck. But new global estimates from the World Health ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced new translational and clinical biomarker data from its Phase 1b C-800-01 trial (NCT03860272) evaluating botensilimab (BOT), an ...

An Indian review reveals how macrophages are reprogrammed inside breast tumours, helping cancer grow and spread while opening new treatment pathways.